Logo image of AGYS

AGILYSYS INC (AGYS) Stock Fundamental Analysis

NASDAQ:AGYS - Nasdaq - US00847J1051 - Common Stock - Currency: USD

68.6  +0.83 (+1.22%)

Fundamental Rating

6

AGYS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. Both the profitability and the financial health of AGYS get a neutral evaluation. Nothing too spectacular is happening here. AGYS shows excellent growth, but is valued quite expensive already. This makes AGYS very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AGYS had positive earnings in the past year.
AGYS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AGYS reported negative net income in multiple years.
Each year in the past 5 years AGYS had a positive operating cash flow.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

AGYS has a Return On Assets of 5.02%. This is in the better half of the industry: AGYS outperforms 75.09% of its industry peers.
The Return On Equity of AGYS (8.67%) is better than 76.14% of its industry peers.
AGYS has a Return On Invested Capital of 6.19%. This is in the better half of the industry: AGYS outperforms 78.60% of its industry peers.
AGYS had an Average Return On Invested Capital over the past 3 years of 5.60%. This is significantly below the industry average of 11.46%.
The last Return On Invested Capital (6.19%) for AGYS is above the 3 year average (5.60%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.02%
ROE 8.67%
ROIC 6.19%
ROA(3y)10.54%
ROA(5y)-0.57%
ROE(3y)16.06%
ROE(5y)-3.96%
ROIC(3y)5.6%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a decent Profit Margin value of 8.45%, AGYS is doing good in the industry, outperforming 73.68% of the companies in the same industry.
AGYS has a Operating Margin of 9.78%. This is in the better half of the industry: AGYS outperforms 76.84% of its industry peers.
AGYS has a Gross Margin of 62.68%. This is comparable to the rest of the industry: AGYS outperforms 43.86% of its industry peers.
AGYS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.78%
PM (TTM) 8.45%
GM 62.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.31%
GM growth 5Y2.97%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AGYS is destroying value.
The number of shares outstanding for AGYS has been increased compared to 1 year ago.
Compared to 5 years ago, AGYS has more shares outstanding
AGYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

AGYS has an Altman-Z score of 7.40. This indicates that AGYS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.40, AGYS belongs to the top of the industry, outperforming 81.05% of the companies in the same industry.
The Debt to FCF ratio of AGYS is 0.69, which is an excellent value as it means it would take AGYS, only 0.69 years of fcf income to pay off all of its debts.
AGYS's Debt to FCF ratio of 0.69 is fine compared to the rest of the industry. AGYS outperforms 74.74% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that AGYS is not too dependend on debt financing.
AGYS's Debt to Equity ratio of 0.15 is in line compared to the rest of the industry. AGYS outperforms 49.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.69
Altman-Z 7.4
ROIC/WACC0.56
WACC10.98%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.14 indicates that AGYS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.14, AGYS is doing worse than 68.42% of the companies in the same industry.
AGYS has a Quick Ratio of 1.09. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AGYS (1.09) is worse than 70.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.09
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

9

3. Growth

3.1 Past

AGYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.85%, which is quite impressive.
The Earnings Per Share has been growing by 10.74% on average over the past years. This is quite good.
Looking at the last year, AGYS shows a quite strong growth in Revenue. The Revenue has grown by 15.52% in the last year.
Measured over the past years, AGYS shows a quite strong growth in Revenue. The Revenue has been growing by 11.02% on average per year.
EPS 1Y (TTM)28.85%
EPS 3Y10.74%
EPS 5YN/A
EPS Q2Q%8.57%
Revenue 1Y (TTM)15.52%
Revenue growth 3Y20.06%
Revenue growth 5Y11.02%
Sales Q2Q%14.85%

3.2 Future

The Earnings Per Share is expected to grow by 25.14% on average over the next years. This is a very strong growth
AGYS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.96% yearly.
EPS Next Y20.17%
EPS Next 2Y23.39%
EPS Next 3Y25.14%
EPS Next 5YN/A
Revenue Next Year14.99%
Revenue Next 2Y15.93%
Revenue Next 3Y17.54%
Revenue Next 5Y21.96%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 51.19, which means the current valuation is very expensive for AGYS.
AGYS's Price/Earnings is on the same level as the industry average.
AGYS is valuated expensively when we compare the Price/Earnings ratio to 27.63, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 40.96 indicates a quite expensive valuation of AGYS.
The rest of the industry has a similar Price/Forward Earnings ratio as AGYS.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.85, AGYS is valued quite expensively.
Industry RankSector Rank
PE 51.19
Fwd PE 40.96
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AGYS indicates a somewhat cheap valuation: AGYS is cheaper than 63.86% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AGYS indicates a somewhat cheap valuation: AGYS is cheaper than 67.72% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 34.73
EV/EBITDA 57.8
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AGYS may justify a higher PE ratio.
AGYS's earnings are expected to grow with 25.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.54
PEG (5Y)N/A
EPS Next 2Y23.39%
EPS Next 3Y25.14%

0

5. Dividend

5.1 Amount

No dividends for AGYS!.
Industry RankSector Rank
Dividend Yield N/A

AGILYSYS INC

NASDAQ:AGYS (4/22/2025, 2:30:56 PM)

68.6

+0.83 (+1.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-21 2025-01-21/amc
Earnings (Next)05-12 2025-05-12/amc
Inst Owners100.8%
Inst Owner Change1%
Ins Owners4.57%
Ins Owner Change-1.44%
Market Cap1.92B
Analysts85.45
Price Target135.92 (98.13%)
Short Float %4.65%
Short Ratio3.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)-11.99%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.5%
Min EPS beat(2)8.77%
Max EPS beat(2)12.23%
EPS beat(4)4
Avg EPS beat(4)11.9%
Min EPS beat(4)8.77%
Max EPS beat(4)15.34%
EPS beat(8)8
Avg EPS beat(8)19.05%
EPS beat(12)12
Avg EPS beat(12)21.65%
EPS beat(16)15
Avg EPS beat(16)19.33%
Revenue beat(2)0
Avg Revenue beat(2)-3.8%
Min Revenue beat(2)-6.77%
Max Revenue beat(2)-0.83%
Revenue beat(4)0
Avg Revenue beat(4)-3.14%
Min Revenue beat(4)-6.77%
Max Revenue beat(4)-0.83%
Revenue beat(8)1
Avg Revenue beat(8)-1.66%
Revenue beat(12)5
Avg Revenue beat(12)-0.3%
Revenue beat(16)6
Avg Revenue beat(16)-1.14%
PT rev (1m)-5.83%
PT rev (3m)-5.66%
EPS NQ rev (1m)-2.22%
EPS NQ rev (3m)-18.87%
EPS NY rev (1m)-0.5%
EPS NY rev (3m)-2.19%
Revenue NQ rev (1m)-0.23%
Revenue NQ rev (3m)-7.21%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-3.24%
Valuation
Industry RankSector Rank
PE 51.19
Fwd PE 40.96
P/S 7.28
P/FCF 34.73
P/OCF 33.19
P/B 7.47
P/tB 35.06
EV/EBITDA 57.8
EPS(TTM)1.34
EY1.95%
EPS(NY)1.67
Fwd EY2.44%
FCF(TTM)1.98
FCFY2.88%
OCF(TTM)2.07
OCFY3.01%
SpS9.43
BVpS9.18
TBVpS1.96
PEG (NY)2.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.02%
ROE 8.67%
ROCE 7.84%
ROIC 6.19%
ROICexc 7.59%
ROICexgc 30.82%
OM 9.78%
PM (TTM) 8.45%
GM 62.68%
FCFM 20.96%
ROA(3y)10.54%
ROA(5y)-0.57%
ROE(3y)16.06%
ROE(5y)-3.96%
ROIC(3y)5.6%
ROIC(5y)N/A
ROICexc(3y)16.08%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.09%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.31%
GM growth 5Y2.97%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.69
Debt/EBITDA 1.17
Cap/Depr 38.56%
Cap/Sales 0.97%
Interest Coverage 250
Cash Conversion 178.39%
Profit Quality 248.11%
Current Ratio 1.14
Quick Ratio 1.09
Altman-Z 7.4
F-Score5
WACC10.98%
ROIC/WACC0.56
Cap/Depr(3y)130.31%
Cap/Depr(5y)87.86%
Cap/Sales(3y)2.6%
Cap/Sales(5y)2.19%
Profit Quality(3y)285.19%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.85%
EPS 3Y10.74%
EPS 5YN/A
EPS Q2Q%8.57%
EPS Next Y20.17%
EPS Next 2Y23.39%
EPS Next 3Y25.14%
EPS Next 5YN/A
Revenue 1Y (TTM)15.52%
Revenue growth 3Y20.06%
Revenue growth 5Y11.02%
Sales Q2Q%14.85%
Revenue Next Year14.99%
Revenue Next 2Y15.93%
Revenue Next 3Y17.54%
Revenue Next 5Y21.96%
EBIT growth 1Y59.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.72%
EBIT Next 3Y54.04%
EBIT Next 5Y48.37%
FCF growth 1Y166.82%
FCF growth 3Y14.05%
FCF growth 5Y88.13%
OCF growth 1Y136.82%
OCF growth 3Y19.27%
OCF growth 5Y46.26%